🔬 Neurochemistry: Chemical Synaptic Transmission
Chemical synaptic transmission is the primary mode of intercellular communication in the central and peripheral nervous systems, converting electrical action potentials into quantal biochemical signals via SNARE-mediated vesicle fusion and postsynaptic receptor activation.
1. The Presynaptic Molecular Cascade: SNARE Machinery
Neurotransmitter release requires sub-millisecond coordination between calcium influx and vesicular docking proteins:
- Action Potential Influx: The terminal depolarization activates presynaptic Cav2.1 (P/Q-type) and Cav2.2 (N-type) voltage-gated calcium channels localized at the presynaptic active zone.
- Microdomain Calcium Spikes: Intracellular $[Ca^{2+}]$ surges locally from ~100 nM to >100 $mu$M within nanometers of the release machinery.
- The Core SNARE Complex: Composed of a 4-helix bundle that pulls the vesicle and plasma membranes together:
- Synaptobrevin / VAMP2: v-SNARE on the vesicle membrane (1 $lpha$-helix).
- Syntaxin-1: t-SNARE on the presynaptic active zone membrane (1 $lpha$-helix).
- SNAP-25: t-SNARE anchored to plasma membrane by palmitoylation (2 $lpha$-helices).
- Synaptotagmin-1 (Calcium Sensor): Contains tandem C2A and C2B domains that bind $Ca^{2+}$ and phospholipids (PIP2), relieving complexin inhibition and triggering lipid pore opening.
Presynaptic SNARE Assembly & Postsynaptic Receptor Activation
Vector SVG
Figure 2.1: The synaptic junction demonstrating Cav2.x channel activation, vesicular SNARE zipper fusion, transmitter release into the 20 nm synaptic cleft, and dual ionotropic/metabotropic postsynaptic reception.
2. Postsynaptic Receptors: Ionotropic vs Metabotropic
| Feature | Ionotropic Receptors (Ligand-Gated Ion Channels) | Metabotropic Receptors (G-Protein Coupled Receptors) |
|---|---|---|
| Structure | Pentasymmetric or tetrameric complex forming an intrinsic ion pore | Single polypeptide with 7 transmembrane $lpha$-helices (7-TM) coupled to heterotrimeric G-proteins |
| Kinetics | Rapid onset (< 1 ms), short duration (tens of ms) | Slow onset (hundreds of ms to seconds), long-lasting (minutes to hours) |
| Primary Mechanism | Direct conformational pore gating causing immediate ion flux | Activation of $G_{lphaetagamma} ightarrow$ second messengers (cAMP, IP3, DAG, $Ca^{2+}$) |
| Classical Examples | AMPA, NMDA, Kainate, $GABA_A$, Glycine, Nicotinic AChR (nAChR), $5-HT_3$ | $mGluR_{1-8}$, $GABA_B$, Muscarinic AChR ($M_{1-5}$), Dopamine ($D_{1-5}$), $lpha/eta$-Adrenergic |
| Signal Amplification | No amplification (1 transmitter opens 1 channel) | Massive intracellular amplification cascade (1 GPCR activates multiple G-proteins & enzymes) |
3. Neurotoxins & Clinical Pathology
- Botulinum Toxins (BoNT/A to G): Produced by Clostridium botulinum. The light chain is a zinc-endopeptidase that enters cholinergic motor terminals and cleaves SNAP-25 or Synaptobrevin, preventing ACh release and causing flaccid paralysis.
- Tetanus Toxin (TeNT): Retrogradely transported from peripheral wound to spinal cord inhibitory interneurons (Renshaw cells), cleaving Synaptobrevin to block glycine and GABA release, causing spastic paralysis and lockjaw.
- Myasthenia Gravis: Autoimmune disease characterized by pathogenic IgG antibodies targeting postsynaptic nicotinic ACh receptors at the neuromuscular junction, inducing receptor internalization and complement-mediated destruction of junctional folds.